Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient.

[1]  E. Barrett-Connor.  Postmenopausal estrogen replacement and breast cancer. , 1989, The New England journal of medicine.

[2]  R. Hoover,et al.  The risk of breast cancer after estrogen and estrogen-progestin replacement. , 1989, The New England journal of medicine.

[3]  M. Whitehead,et al.  PROGESTAGEN USE IN POSTMENOPAUSAL WOMEN , 1988, The Lancet.

[4]  P. Brenner.  The Menopausal Syndrome , 1988, Obstetrics and gynecology.

[5]  M. Pike,et al.  Re-evaluating the role of progestogen therapy after the menopause. , 1988, Fertility and sterility.

[6]  J. Barboriak,et al.  Postmenopausal use of estrogen and occlusion of coronary arteries. , 1988, American heart journal.

[7]  J. Gallagher,et al.  Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin. , 1988, The Journal of reproductive medicine.

[8]  J. Shepherd,et al.  Continuous estrogen/progestin therapy in menopause. , 1987, American journal of obstetrics and gynecology.

[9]  T. Clarkson,et al.  Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. , 1987, Fertility and sterility.

[10]  L. Weinstein.  Efficacy of a Continuous Estrogen‐Progestin Regimen in the Menopausal Patient , 1987, Obstetrics and gynecology.

[11]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[12]  V. Ravnikar.  Compliance with hormone therapy. , 1987, American journal of obstetrics and gynecology.

[13]  M. Whitehead,et al.  Assessment of the potency of orally administered progestins in women. , 1986, Fertility and sterility.

[14]  M. Whitehead,et al.  A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving Estrogens , 1986 .

[15]  L. Nachtigall,et al.  Is estrogen replacement therapy necessary? , 1985, The Journal of reproductive medicine.

[16]  B. Henderson,et al.  Estrogen use and cardiovascular disease. , 1986, American journal of obstetrics and gynecology.

[17]  J. Studd,et al.  Amenorrhea and Endometrial Atrophy With Continuous Oral Estrogen and Progestogen Therapy in Postmenopausal Women , 1985, Obstetrics and gynecology.

[18]  B. V. VON Schoultz,et al.  Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone. , 1985, American journal of obstetrics and gynecology.

[19]  C. Bengtsson,et al.  MENOPAUSAL AGE AND RISK OF CARDIOVASCULAR DISEASE AND DEATH , 1985, Acta obstetricia et gynecologica Scandinavica. Supplement.

[20]  G. Phillips,et al.  Detection of postmenopausal women at risk for endometrial carcinoma by a progesterone challenge test. , 1983, American journal of obstetrics and gynecology.

[21]  Ziel Hk.  Estrogen's role in endometrial cancer. , 1982 .

[22]  H. Mcgill,et al.  Hormone Receptors of the Baboon Cardiovascular System: Biochemical Characterization of Aortic and Myocardial Cytoplasmic Progesterone Receptors , 1982, Circulation research.

[23]  O. Ylikorkala,et al.  Regulation of prostacyclin and thromboxane production by human umbilical vessels: the effect of estradiol and progesterone in a superfusion model. , 1982, Prostaglandins, leukotrienes, and medicine.

[24]  T. Anderson,et al.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. , 1981, British Journal of Cancer.

[25]  B. Lewis,et al.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. , 1981, British medical journal.

[26]  R. E. Johnson,et al.  The risk of hip fracture in postmenopausal females with or without estrogen drug exposure. , 1981, American journal of public health.

[27]  N. Weiss,et al.  Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. , 1980, The New England journal of medicine.

[28]  W. Creasman,et al.  Effects of long-term estrogen replacement therapy: II. Neoplasia , 1979 .

[29]  R. Megraw,et al.  Manual and continuous-flow colorimetry of triacylglycerols by a fully enzymic method. , 1979, Clinical chemistry.

[30]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[31]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.